ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 247

$620K Total Retail Price of All Prescriptions

Rank: 22 out of 247

602 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,741 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 413 304 1 1
LEVOTHYROXINE SODIUM 408 377 2 3
OMEPRAZOLE 349 274 3 4
FUROSEMIDE 339 303 4 5
LISINOPRIL 330 277 5 2
METFORMIN HCL 296 175 6 12
METOPROLOL TARTRATE 245 217 7 7
ATORVASTATIN CALCIUM 240 179 8 8
HYDROCODONE-ACETAMINOPHEN 191 115 S3 9 11
AMLODIPINE BESYLATE 156 117 10 6
HYDROCHLOROTHIAZIDE 155 125 11 9
SPIRIVA 136 124 12 26
PANTOPRAZOLE SODIUM 135 113 13 19
TAMSULOSIN HCL 129 122 14 31
FENOFIBRATE 126 63 15 75
GABAPENTIN 119 74 16 17
CITALOPRAM HBR 118 117 17 20
WARFARIN SODIUM 111 90 18 13
ZOLPIDEM TARTRATE 109 89 19 24
CRESTOR 102 93 20 30
ADVAIR DISKUS 94 84 21 18
LOVASTATIN 86 86 22 22
ALLOPURINOL 81 74 23 33
PROAIR HFA 77 55 24 29
PREDNISONE 77 70 24 21
ATENOLOL 75 43 26 10
PRAVASTATIN SODIUM 72 57 27 23
PAROXETINE HCL 71 62 28 45
VENLAFAXINE HCL ER 70 0 29 64
METOPROLOL SUCCINATE 70 68 29 14
TRAMADOL HCL 69 38 31 25
LANTUS 68 58 32 39
LIPITOR 66 42 33 50
NEXIUM 65 41 34 42
DOXYCYCLINE HYCLATE 64 48 35 139
ROPINIROLE HCL 62 60 36 69
TRAZODONE HCL 60 44 37 28
SERTRALINE HCL 58 16 38 16
OXYCODONE HCL 51 31 S2 39 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.